Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HTR1D | P28221 | 2/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 7/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | HTR1B | P28222 | 1/20 | 0.36 |
| ▸ | SPR | P35270 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MPO | P05164 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1083534 | 0.87 | CASP1 (0.40) | KMT2AMEN1HCRTR1HTR1DMTNR1A | |
| SCHEMBL1047567 | 0.84 | HTR1D (0.39) | KMT2AMEN1HCRTR1HTR1DMTNR1A | |
| SCHEMBL5050472 | 0.83 | HTR1D (0.35) | KMT2AMEN1HCRTR1HTR1DMTNR1A | |
| SCHEMBL1051032 | 0.81 | HTR1D (0.36) | KMT2AHTR1DMTNR1AMTNR1BTRPV1 | |
| SCHEMBL1049891 | 0.81 | MTNR1A (0.35) | KMT2AMEN1MTNR1AMTNR1BTRPV1 | |
| Hydrochloric Acid SCHEMBL5164080 | 0.79 | HTR1D (0.40) | KMT2AMEN1HTR1DMTNR1AMTNR1B | |
| SCHEMBL4539260 | 0.78 | HTR1D (0.38) | HTR1DMTNR1AMTNR1BTRPV1PTGS2 | |
| SCHEMBL3769416 | 0.78 | HTR1D (0.38) | HTR1DMTNR1AMTNR1BTRPV1PTGS2 | |
| SCHEMBL1049206 | 0.77 | HTR1D (0.36) | KMT2AHTR1DMTNR1AMTNR1BTRPV1 | |
| SCHEMBL1049543 | 0.76 | HTR1D (0.39) | HTR1DMTNR1AMTNR1BTRPV1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7868036-B2 | Organic compounds | NOVARTIS AG (CH) | 2011-01-11 | — | — | US | disclosed |
| US-20080058320-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058320-A1 | Organic Compounds | REN, AGTR1, ADH1C | KMT2A 3647/4885MEN1 1572/4885HCRTR1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.